Insights

Strategic Growth Phase Genomics is expanding its market presence with a new Chief Business Officer appointed in 2024 to drive growth and broader market awareness, signaling readiness for scaled partnerships and enterprise deals.

Collaborative Opportunities Active collaboration with Lumen Bioscience and Gates Foundation-backed projects indicate openness to joint development programs, enabling co-funded research and potential licensing or access to Phase Genomics’ proximity-ligation sequencing platforms.

Platform Expansion Aiming to deploy platforms for antimicrobial discovery and pathogen-related applications, there are selling points for labs and biotechs focused on infectious disease, antimicrobial resistance, and One Health initiatives seeking advanced genomic tools.

Advanced Capabilities Proximo, ProxiMeta and Genomic Proximity Mapping offer high-resolution, chromosomal-scale assemblies and metagenomic insights, which can be positioned to academic groups and industry partners pursuing complex genome projects and cytogenetics workflows.

Strategic Funding Signals Recognition as Metagenomics Innovation of the Year and ongoing AI/ChAOS development signals a forward-looking portfolio; this can be leveraged to engage customers seeking cutting-edge genomic analytics, AI-driven diagnostics, and value-added data products.

Similar companies to Phase Genomics

Phase Genomics Tech Stack

Phase Genomics uses 8 technology products and services including HubSpot Analytics, Ansible, HashiCorp Terraform, and more. Explore Phase Genomics's tech stack below.

Media & News

Phase Genomics's Email Address Formats

Phase Genomics uses at least 3 email formats:
Phase Genomics Email FormatsExamplePercentage
First@phasegenomics.comJohn@phasegenomics.com
90%
FLast@phasegenomics.comJDoe@phasegenomics.com
8%
Middle@phasegenomics.comMichael@phasegenomics.com
2%

Frequently Asked Questions

What is Phase Genomics's official website and social media links?

Minus sign iconPlus sign icon
Phase Genomics's official website is phasegenomics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Phase Genomics generate?

Minus sign iconPlus sign icon
As of October 2026, Phase Genomics's annual revenue is estimated to be $10M - $25M.

What is Phase Genomics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Phase Genomics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Phase Genomics have currently?

Minus sign iconPlus sign icon
As of October 2026, Phase Genomics has approximately 14 employees across 2 continents, including North America and Africa. Key team members include Director Of Metagenomics: B. A., Product Marketing Manager: K. A. and Research Scientist: K. L. Explore Phase Genomics's employee directory with LeadIQ.

What industry does Phase Genomics belong to?

Minus sign iconPlus sign icon
Phase Genomics operates in the Biotechnology Research industry.

What technology does Phase Genomics use?

Minus sign iconPlus sign icon
Phase Genomics's tech stack includes HubSpot Analytics, Ansible, HashiCorp Terraform, HubSpot Content Hub, PostgreSQL, Amazon SageMaker, PayPal and Piwik.

What is Phase Genomics's email format?

Minus sign iconPlus sign icon
Phase Genomics's email format typically follows the pattern of First@phasegenomics.com. Find more Phase Genomics email formats with LeadIQ.

How much funding has Phase Genomics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Phase Genomics has raised $17M in funding. The last funding round occurred on Mar 04, 2024 for $1.5M.

When was Phase Genomics founded?

Minus sign iconPlus sign icon
Phase Genomics was founded in 2015.
Phase Genomics logo

Phase Genomics

Biotechnology ResearchWashington, United States11-50 Employees

Phase Genomics is a biotechnology company that provides genomic sequencing and computational analysis tools for health and environmental research. Its platform supports ultra-long-range sequencing and related analytics to illuminate the genomic landscape across projects in human health, agriculture, and infectious disease. The company is based in Seattle, Washington, and serves academic and industry researchers worldwide through a network of distribution partners; it was founded in 2015 by genome scientists, engineers, and entrepreneurs.

Phase Genomics targets researchers in both academia and industry who require high-resolution genomic information to address complex problems. In April 2025, the company participated in the AACR Annual Meeting and presented data related to Genomic Proximity Mapping for next-generation cytogenetics.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $17M

    Phase Genomics has raised a total of $17M of funding over 10 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $1.5M as a Grant.

  • $10M - $25M

    Phase Genomics's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.